Adma Biologics, Inc. (NASDAQ: ADMA)

$10.79 -0.09 (-0.83%)
As of Apr 21, 2026 03:59 PM
Sector: Healthcare Industry: Biotechnology CIK: 0001368514
Market Cap 2.56 Bn
P/E 17.59
P/S 5.01
Div. Yield 0.00
ROIC (Qtr) 0.34
Total Debt (Qtr) 72.14 Mn
Revenue Growth (1y) (Qtr) 18.39
Add ratio to table...

About

Consolidation Items Breakdown of Revenue (2025)

Breakdown of Revenue (2025)

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 VRTX Vertex Pharmaceuticals Inc / Ma 111.34 Bn 28.15 9.28 -
2 REGN Regeneron Pharmaceuticals, Inc. 78.06 Bn 17.30 5.44 1.99 Bn
3 ALNY Alnylam Pharmaceuticals, Inc. 41.92 Bn 152.39 13.31 -
4 RVMD Revolution Medicines, Inc. 28.36 Bn -25.11 34,170.56 -
5 ZLAB Zai Lab Ltd 25.77 Bn -147.06 106.30 0.20 Bn
6 MESO Mesoblast Ltd 24.32 Bn -190.54 1,414.27 0.12 Bn
7 MRNA Moderna, Inc. 21.25 Bn -7.52 10.93 0.59 Bn
8 RPRX Royalty Pharma plc 20.83 Bn 27.08 8.76 8.95 Bn